NCT07050043 2025-07-03
LEDANG
Hospital Sultanah Bahiyah
Phase 3 Recruiting
Clinical Trials
11 trialsNCT06786312 2025-01-22
A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT05377658 2024-02-21
AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer
Henan Cancer Hospital
Phase 2 Recruiting
NCT06208033 2024-01-17
SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)
Fujian Cancer Hospital
Phase EARLY_PHASE1 Unknown
NCT05832827 2023-10-23
Artemis
National Cancer Center, Japan
Phase 2 Recruiting
NCT02737774 2020-07-01
Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation
Henan Cancer Hospital
Phase 2 Unknown
NCT03790228 2020-04-15
Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC
Henan Cancer Hospital
Phase 1 Unknown
NCT02804646 2016-06-21
Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma
Anhui Provincial Hospital
Phase 4 Unknown
NCT02738346 2016-04-25
CBPC
University Hospital, Angers
Phase 3 Unknown
NCT01836575 2013-04-22
PS2
Instituto Nacional de Cancer, Brazil
Phase 3 Completed
NCT00563160 2010-07-07
Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery
Hospital Authority, Hong Kong
Phase 2 Unknown